Sage Therapeutics Inc (SAGE) Event Aug. 02, 2022, 00:00 UTC 20 1 comments (66% Neutral) Sage Therapeutics, Inc. (SAGE) Reports Net Loss for 2022-06-30 Comment Full text
Phathom Pharmaceuticals Inc (PHAT) Event Aug. 02, 2022, 00:00 UTC 24 1 comments (61% Neutral) PHATHOM PHARMACEUTICALS, INC. (PHAT) Reports Net Loss for 2022-06-30 Comment Full text
Esperion Therapeutics Inc (ESPR) Event Aug. 02, 2022, 00:00 UTC 24 1 comments (42% Neutral) Esperion Therapeutics, Inc. (ESPR) Reports Net Loss for 2022-06-30 Comment Full text
Rigel Pharmaceuticals Inc (RIGL) Event Aug. 02, 2022, 00:00 UTC 24 1 comments (99% Positive) RIGEL PHARMACEUTICALS INC (RIGL) Reports 163% Profit Growth for 2022-06-30 Comment Full text
Evolus Inc (EOLS) Event Aug. 02, 2022, 00:00 UTC 22 1 comments (47% Neutral) EVOLUS, INC. (EOLS) Reports 75% Loss Increase for 2022-06-30 Comment Full text
Amicus Therapeutics Inc (FOLD) Event Aug. 01, 2022, 21:10 UTC 14 1 comments (99% Neutral) AMICUS THERAPEUTICS, INC. (FOLD) Announces New Board Appointment Comment Full text
Acumen Pharmaceuticals Inc (ABOS) Event Aug. 01, 2022, 21:06 UTC 14 1 comments (99% Neutral) Acumen Pharmaceuticals, Inc. (ABOS) Provides Update on appear for Alzheimer’s disease (AD) Comment Full text
Aclaris Therapeutics Inc (ACRS) Event Aug. 01, 2022, 20:45 UTC 14 1 comments (99% Neutral) Aclaris Therapeutics, Inc. (ACRS) Announces New Board Appointment Comment Full text
Cellectis (CLLS) Event Aug. 01, 2022, 20:30 UTC 11 1 comments (99% Neutral) Cellectis (CLLS) Announces Clinical Development Update (Form 6-K) Comment Full text
Aerie Pharmaceuticals Inc (the company is taken over Alcon (ALC)) (AERI) Event Aug. 01, 2022, 20:21 UTC 12 1 comments (85% Positive) AERIE PHARMACEUTICALS INC (AERI) Announces Enrollment Update for trials Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text